Short-half-life topical beta blockers with permeation enhancers target hemangiomas locally while limiting systemic exposure and side effects.
By reversibly disrupting the basement membrane, this patch broadens transdermal delivery to larger drugs with faster local or systemic uptake.
Biodegradable suramin hydrogels use sustained release to move chronic wounds beyond prolonged inflammation and support healing.
A patterned hydrogel on an electrospun nanoporous membrane enables localized, quantitative BMP or anticancer drug release while limiting side effects.
Ester-free crosslinking between multi-arm polymers and polyamino compounds creates hydrogels with long-term in vivo stability and radiopacity.
Decellularized amniotic membrane hydrogel preserves ECM proteins while removing cells, improving biocompatibility and scalability for tissue scaffolds.